Gall Bladder Cancer  >>  epirubicin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT01053390: New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

Completed
3
216
RoW
Somatostatin, epirubicin, cisplatin, LV(Leucovorin)、 5-FU(5-Fluorouracil)
Shanghai Jiao Tong University School of Medicine, Xuanwu Hospital, Beijing, Capital Medical University, Peking University First Hospital, Tianjin Medical University Cancer Institute and Hospital, The First Affiliated Hospital of Dalian Medical University, China Medical University, China, The first clinical college of harbin medical university, The Second Affiliated Hospital of Harbin Medical University, Shengjing Hospital, Jilin University, The people's hospital of Heilongjiang province, Eastern Hepatobiliary Surgery Hospital, Shanghai Changzheng Hospital, Shandong Provincial Hospital, Qilu Hospital of Shandong University, Air Force Military Medical University, China, Tang-Du Hospital, Qinghai People's Hospital, Affiliated Hospital of Qinghai University, First Affiliated Hospital of Chongqing Medical University, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, First People's Hospital of Kunming, Lanzhou university second hospital, Xi'an Central Hospital, The first people's hospital of Guiyang, Southwest Hospital, China, The First Affiliated Hospital of Kunming Medical College
Gallbladder Neoplasms
12/13
12/13

Download Options